Stock listing

NASDAQ:QTTB Q32 Bio Inc. Stock

Home listing (NASDAQ) of Q32 Bio Inc.

Follow Q32 Bio Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:QTTB

$8.34 USD -0.19 (-2.2%)

Close on Nov 20, 2026

Past year +332.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$8.23 – $8.59 USDNov 20, 2026
Volume
476,717 sharesNov 20, 2026
Market cap
$249.6M USDAt the close on Nov 20, 2026 · price × 29.92M shares outstanding
52-week range
$1.93 – $23.57 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$6.66M USDMedian day 506,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Q32 Bio Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:QTTB · Home$8.34 USD-0.19 (-2.2%)476,717$8.36$8.59$8.23$8.53Close on Nov 20, 2026
LSE:0T6G$8.402 USD-0.028 (-0.3%)34$8.16$8.402$8.16$8.43Close on Nov 20, 2026
Frankfurt:DB0€7.535 EUR-0.08 (-1.1%)—€7.20€7.535€7.20€7.615Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:QTTB · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$8.34-0.19-2.2%$8.36$8.59$8.23476,717
$8.53-0.10-1.2%$8.585$9.08$8.50261,838
$8.63+0.34+4.1%$8.27$8.73$8.06621,205
$8.29-0.42-4.8%$8.66$8.73$8.251344,084
$8.71-0.11-1.2%$8.83$8.86$8.45243,793
$8.82-0.38-4.1%$9.15$9.15$8.53355,589
$9.20-0.13-1.4%$9.39$9.44$9.13236,085
$9.33-0.01-0.1%$9.21$9.74$9.21324,308
$9.34+0.09+1.0%$9.35$9.65$9.01413,223
$9.25+0.40+4.5%$8.83$9.34$8.83214,625
$8.85-0.12-1.3%$8.91$8.93$8.23583,246
$8.97+0.21+2.4%$8.865$9.17$8.52215,502
$8.76+0.05+0.6%$8.68$9.035$8.68175,200
$8.71-0.20-2.2%$8.89$9.00$8.545246,692
$8.91+0.04+0.5%$8.87$8.98$8.53268,080
$8.87-0.19-2.1%$9.20$9.349$8.86317,788
$9.06+0.35+4.0%$8.65$9.11$8.51409,200
$8.71+0.26+3.1%$8.52$8.82$8.429692,575
$8.45-0.20-2.3%$8.60$8.825$8.39563,686
$8.65-0.15-1.7%$8.80$8.835$8.30404,000
$8.80+0.13+1.5%$8.67$9.01$8.60363,600
$8.67+0.05+0.6%$8.62$8.81$8.55322,100
$8.62+0.83+10.7%$7.79$8.84$7.79506,100
$7.79+0.27+3.6%$7.52$7.94$7.52609,900
$7.52-0.25-3.2%$7.82$7.82$7.28678,000
$7.77-0.24-3.0%$8.01$8.29$7.72625,300
$8.01-0.05-0.6%$7.93$8.30$7.72889,300
$8.06-0.68-7.8%$8.69$8.69$7.89719,800
$8.74+0.40+4.8%$8.64$9.155$8.44682,300
$8.34+0.25+3.1%$8.125$8.46$7.94854,600
$8.09+0.10+1.3%$7.94$8.12$7.62859,600
$7.99-0.12-1.5%$8.00$8.07$7.83569,600
$8.11-0.26-3.1%$8.32$8.36$7.80678,400
$8.37+0.14+1.7%$8.09$8.56$7.81954,800
$8.23-0.02-0.2%$8.35$9.11$8.172,097,000
$8.25-0.02-0.2%$8.36$8.85$7.753,085,900
$8.27-1.26-13.2%$10.40$10.40$7.8785,250,500
$9.53+0.30+3.3%$9.32$9.665$9.164914,800
$9.23+0.46+5.2%$9.21$9.445$8.771,004,900
$8.77-0.45-4.9%$9.20$9.20$8.74514,800
$9.22-0.34-3.6%$9.51$9.55$9.051,075,000
$9.56-1.01-9.6%$10.58$10.58$9.50828,400
$10.57+0.10+1.0%$10.60$10.99$10.53387,200
$10.47-0.07-0.7%$10.57$10.75$10.30359,000
$10.54-0.32-2.9%$10.84$10.97$10.46972,300
$10.86-0.12-1.1%$11.14$11.17$10.69384,000
$10.98-0.19-1.7%$11.17$11.41$10.87504,900
$11.17+0.26+2.4%$10.77$11.29$10.51602,500
$10.91-0.19-1.7%$10.96$11.28$10.63870,600
$11.10+0.38+3.5%$10.82$11.27$10.451,824,300
$10.72-0.42-3.8%$11.00$11.08$10.54937,600
$11.14-0.55-4.7%$11.61$11.95$11.07488,700
$11.69-0.30-2.5%$12.00$12.00$11.57592,900
$11.99-0.81-6.3%$12.60$12.70$11.50851,500
$12.80-0.79-5.8%$13.52$13.59$12.74491,500
$13.59-0.77-5.4%$14.42$14.55$13.35434,600
$14.36-0.51-3.4%$14.77$14.77$14.18331,400
$14.87-0.16-1.1%$14.85$15.32$14.75349,900
$15.03-1.12-6.9%$15.91$16.25$14.92353,400
$16.15-0.03-0.2%$16.08$16.30$15.93203,300
$16.18-0.14-0.9%$16.13$16.52$15.80327,100
$16.32-0.04-0.2%$16.36$16.98$16.06599,089
$16.36+0.39+2.4%$16.50$16.66$15.50691,058
$15.97+0.11+0.7%$15.89$16.29$15.72341,400
$15.86+0.02+0.1%$15.80$16.15$15.51389,100

Splits

1 split · NASDAQ:QTTB · every price before a split is adjusted for it

DayRatioWhat
1-for-18Consolidation
Ticker
NASDAQ:QTTB
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Q32 Bio Inc. news

Financings

  • Public offering of common stock and pre-funded warrants

    Aug 5, 2026

    Closed: US$200M raised · US$18.25 a share · Morgan Stanley +4

    Dealers: Morgan Stanley (co-lead), Jefferies (co-lead), Cantor (co-lead), Oppenheimer & Co., H.C. Wainwright & Co.

    Use of proceeds: With existing cash, fund operations through topline Phase 3 results of the planned registration-directed bempikibart program in severe or very severe AA

    Announced Jul 13, 2026 · Update Jul 15, 2026 · Closed Aug 5, 2026

  • At-the-market programme of common stock

    May 5, 2026

    Tranche closed: US$14.2M raised

    Tranche closed May 5, 2026

  • Registered direct offering of common stock and pre-funded warrants

    Feb 17, 2026

    Announced: US$10.5M · US$3.9 a share

    Use of proceeds: Working capital, including research, clinical development and commercialization, and advancing bempikibart into future alopecia areata trials

    Announced Feb 17, 2026

Read by 6ix AI from the company's releases

Decks

Q32 Bio Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 109 in all · newest Nov 11, 2026 · oldest 2020
Decks
7 decks · latest Sep 30, 2026

Where Q32 Bio Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:QTTB · Home listing · This pageNASDAQUnited StatesUSD
gettex:DB0gettexGermanyEUR
Lang & Schwarz:A4ZZ0ZLang & SchwarzGermanyEUR
LSE:0T6GLSEUnited KingdomUSD
BOATS:QTTBBOATSUnited StatesUSD
Dusseldorf:DB0DusseldorfGermanyEUR
Frankfurt:DB0FrankfurtGermanyEUR
Munich:DB0MunichGermanyEUR
Stuttgart:DB0StuttgartGermanyEUR
Tradegate:DB0TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Q32 Bio Inc.